ExGraft is a fully synthetic ePTFE (expandable) vascular graft.
The device combines the performance of ePTFE with the addition of a new radio-opaque design.
This first-class combination improves visibility of graft placement and orientation during surgery and follow-up.
The first ePTFE vascular graft characterized by:
- Radiopaque markers on the outer surface for better visualization by X-ray, CT, post-implant fluoroscopy;
- Controlled and minimally invasive expandability using standard techniques (angioplasty balloon).
- Growth potential for pediatrics without the need for repeated surgery to replace grafts;
- Increase of the original diameter of the inner lumen of the conduit following balloon angioplasty, to delay or reduce the incidence of restenosis.
Radiopaque markers improve the display of:
- Positioning and orientation of the graft;
Twisting and bending;
Original inner diameter marked with a number;
Current diameter calculated using radiopaque circular signs.
Founded in 2012, it is a spin-off of Carnegie Mellon University and Pittsburgh University.
Their passion is the development of advanced devices for cardiothoracic and vascular surgery.